Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Peter W Lewis

Showing results (31-40 of 57) with videos related to

Pageof 6
Sort By:
Cell Cycle (Georgetown, Tex.)|November 5, 2016
Histone chaperone ASF1B promotes human β-cell proliferation via recruitment of histone H3.3Pradyut K Paul, Mary E Rabaglia, Chen-Yu Wang, et al.
Molecular Cell|February 25, 2019
Continued Activity of the Pioneer Factor Zelda Is Required to Drive Zygotic Genome ActivationStephen L McDaniel, Tyler J Gibson, Katharine N Schulz, et al.
Genes & Development|November 6, 2007
Genomic profiling and expression studies reveal both positive and negative activities for the Drosophila Myb MuvB/dREAM complex in proliferating cellsDaphne Georlette, Soyeon Ahn, David M MacAlpine, et al.
Nature Structural & Molecular Biology|June 14, 2011
ATRX ADD domain links an atypical histone methylation recognition mechanism to human mental-retardation syndromeShigeki Iwase, Bin Xiang, Sharmistha Ghosh, et al.
Science (New York, N.Y.)|March 30, 2013
Inhibition of PRC2 activity by a gain-of-function H3 mutation found in pediatric glioblastomaPeter W Lewis, Manuel M Müller, Matthew S Koletsky, et al.
Acta Neuropathologica|September 10, 2014
A sensitive and specific histopathologic prognostic marker for H3F3A K27M mutant pediatric glioblastomasSriram Venneti, Mariarita Santi, Michelle Madden Felicella, et al.
Science Advances|June 19, 2026
Pioneer-factor activity requires stable chromatin occupancy mediated by both sequence-specific binding and disordered protein domainsMeghan M Freund, F Javier deHaro-Arbona, Sarah Baloul, et al.
Proceedings of the National Academy of Sciences of the United States of America|October 17, 2020
Histone H3.3 G34 mutations promote aberrant PRC2 activity and drive tumor progressionSiddhant U Jain, Sima Khazaei, Dylan M Marchione, et al.
Biorxiv : the Preprint Server for Biology|July 25, 2025
SUZ12-Nucleic Acid Interactions Constrain PRC2 Activity to Maintain Targeted Gene Silencing Essential to Diffuse Midline GliomaTyler J Reich, Paul A Clark, Audrey Baguette, et al.
Nature Communications|May 16, 2019
PFA ependymoma-associated protein EZHIP inhibits PRC2 activity through a H3 K27M-like mechanismSiddhant U Jain, Truman J Do, Peder J Lund, et al.
Pageof 6

Showing results (31-40 of 57) with videos related to

Sort By:
Pageof 6
Cell Cycle (Georgetown, Tex.)|November 5, 2016
Histone chaperone ASF1B promotes human β-cell proliferation via recruitment of histone H3.3Pradyut K Paul, Mary E Rabaglia, Chen-Yu Wang, et al.
Molecular Cell|February 25, 2019
Continued Activity of the Pioneer Factor Zelda Is Required to Drive Zygotic Genome ActivationStephen L McDaniel, Tyler J Gibson, Katharine N Schulz, et al.
Genes & Development|November 6, 2007
Genomic profiling and expression studies reveal both positive and negative activities for the Drosophila Myb MuvB/dREAM complex in proliferating cellsDaphne Georlette, Soyeon Ahn, David M MacAlpine, et al.
Nature Structural & Molecular Biology|June 14, 2011
ATRX ADD domain links an atypical histone methylation recognition mechanism to human mental-retardation syndromeShigeki Iwase, Bin Xiang, Sharmistha Ghosh, et al.
Science (New York, N.Y.)|March 30, 2013
Inhibition of PRC2 activity by a gain-of-function H3 mutation found in pediatric glioblastomaPeter W Lewis, Manuel M Müller, Matthew S Koletsky, et al.
Acta Neuropathologica|September 10, 2014
A sensitive and specific histopathologic prognostic marker for H3F3A K27M mutant pediatric glioblastomasSriram Venneti, Mariarita Santi, Michelle Madden Felicella, et al.
Science Advances|June 19, 2026
Pioneer-factor activity requires stable chromatin occupancy mediated by both sequence-specific binding and disordered protein domainsMeghan M Freund, F Javier deHaro-Arbona, Sarah Baloul, et al.
Proceedings of the National Academy of Sciences of the United States of America|October 17, 2020
Histone H3.3 G34 mutations promote aberrant PRC2 activity and drive tumor progressionSiddhant U Jain, Sima Khazaei, Dylan M Marchione, et al.
Biorxiv : the Preprint Server for Biology|July 25, 2025
SUZ12-Nucleic Acid Interactions Constrain PRC2 Activity to Maintain Targeted Gene Silencing Essential to Diffuse Midline GliomaTyler J Reich, Paul A Clark, Audrey Baguette, et al.
Nature Communications|May 16, 2019
PFA ependymoma-associated protein EZHIP inhibits PRC2 activity through a H3 K27M-like mechanismSiddhant U Jain, Truman J Do, Peder J Lund, et al.
Pageof 6